Epub 2012 Sep 1.
Optimal warfarin management for the prevention of thromboembolic events in patients with atrial fibrillation: a systematic review of the clinical evidence
- PMID: 23002382
- PMCID: PMC3442618
Item in Clipboard
Optimal warfarin management for the prevention of thromboembolic events in patients with atrial fibrillation: a systematic review of the clinical evidence
CADTH Technol Overv.
2012.
No abstract available
Similar articles
-
Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation).J Am Coll Cardiol. 2014 Mar 25;63(11):1082-7. doi: 10.1016/j.jacc.2013.09.062. Epub 2013 Nov 6. J Am Coll Cardiol. 2014. PMID: 24211508 Clinical Trial.
-
Indobufen: an updated review of its use in the management of atherothrombosis.Drugs Aging. 2001;18(5):369-88. doi: 10.2165/00002512-200118050-00007. Drugs Aging. 2001. PMID: 11392445 Review.
-
Antiarrhythmic prophylaxis vs warfarin anticoagulation to prevent thromboembolic events among patients with atrial fibrillation. A decision analysis.Arch Intern Med. 1995 May 8;155(9):913-20. Arch Intern Med. 1995. PMID: 7726699
-
Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.Lancet. 1994 Mar 19;343(8899):687-91. Lancet. 1994. PMID: 7907677 Clinical Trial.
-
Prevention of thromboembolic events in atrial fibrillation.Thromb Haemost. 1997 Jul;78(1):377-81. Thromb Haemost. 1997. PMID: 9198182 Review.
References
-
- Menke J, Luthje L, Kastrup A, Larsen J. Thromboembolism in atrial fibrillation. Am J Cardiol. 2010 Feb 15;105(4):502–10. - PubMed
-
- Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med. 2010 Jul;123(7):638–45. - PubMed
-
- Marinigh R, Lip GY, Fiotti N, Giansante C, Lane DA. Age as a risk factor for stroke in atrial fibrillation patients implications for thromboprophylaxis: Implications for thromboprophylaxis. J Am Coll Cardiol. 2010 Sep 7;56(11):827–37. - PubMed
-
- Savelieva I, Bajpai A, Camm AJ. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices. Ann Med. 2007;39(5):371–91. - PubMed
-
- Hankey GJ. Replacing aspirin and warfarin for secondary stroke prevention: is it worth the costs? Curr Opin Neurol. 2010 Feb;23(1):65–72. - PubMed
LinkOut - more resources
Full Text Sources